• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • US
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Products
    • US Products By Brand
    • Patient Assistance
    • Product Portfolio
    • Our Process
    • Therapeutic Areas
    • Product Related Issues
  • About Us
    • Novartis US at a Glance
    • Who We Are
    • Diversity and Inclusion
    • Our Leadership
    • Supplier Diversity
    • Research
    • Contact Us
  • Corporate Responsibility
    • Novartis in Society US Reports
    • Corporate Citizenship
    • Business Conduct
    • Corporate Integrity Agreement
    • Payments to HCPs & HCOs
    • Post-Marketing Commitments
    • Enhanced Verification Request
  • News
    • News Archive
    • Statements
    • Stories
    • US Media Contacts
    • Novartis US COVID-19 Initiatives
  • Careers
    • Careers Search
    • Working at Novartis
    • Employee Benefits
    • Awards & Recognition
    • NIBR Careers Frequently Asked Questions
Search

Notice to Healthcare Providers and Entities

Letter to HCPs

Novartis enters into Corporate Integrity Agreement with Office of Inspector General (OIG) of the US Department of Health & Human Services

Read More (PDF 0.1 MB)

    • Share
      • Email
    • Jump to Comments
  • Print
  • Save

Related Links

  • Compliance Program
  • New policy related to the 340B program
  • Contact
  • Novartis in Society US Reports

You are here

  1. Home ›
  2. News ›
  3. Statements

Novartis United States

  • Our Products
  • About Us
  • News
  • Careers
  • Contact Us
  • Corporate Responsibility
  • Locations

Subscribe to Novartis

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Instagram
  • Novartis Site Directory
© 2021 Novartis Pharmaceuticals Corporation

This site is intended for US Residents Only

  • Terms of Use
  • Privacy Policy
  • About Cookies